HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Cao Selected Research

human PRRT2 protein

1/2020The Phenotypic and Genetic Spectrum of Paroxysmal Kinesigenic Dyskinesia in China.
1/2018Proline-rich transmembrane protein 2-negative paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 163 patients.
12/2014PRRT2 truncated mutations lead to nonsense-mediated mRNA decay in Paroxysmal Kinesigenic Dyskinesia.
12/2011Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Cao Research Topics

Disease

68Neoplasms (Cancer)
06/2022 - 02/2003
27Infections
08/2022 - 10/2003
25Inflammation (Inflammations)
01/2022 - 11/2008
17Breast Neoplasms (Breast Cancer)
05/2022 - 05/2010
17Nasopharyngeal Carcinoma
01/2019 - 01/2000
14Osteoarthritis
03/2022 - 01/2010
13Neoplasm Metastasis (Metastasis)
01/2022 - 10/2005
11Demyelinating Diseases (Demyelinating Disease)
09/2021 - 04/2008
10Carcinogenesis
11/2017 - 07/2005
9Fibrosis (Cirrhosis)
12/2022 - 09/2013
9Pain (Aches)
12/2021 - 06/2008
7Liver Cirrhosis (Hepatic Cirrhosis)
06/2022 - 08/2004
7Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2021 - 05/2015
7Bulimia (Binge Eating)
01/2020 - 10/2011
6Stomach Neoplasms (Stomach Cancer)
05/2022 - 11/2015
6Weight Loss (Weight Reduction)
12/2021 - 07/2017
6Hypoxia (Hypoxemia)
09/2021 - 10/2012
5Hepatocellular Carcinoma (Hepatoma)
06/2022 - 01/2016
5Necrosis
01/2022 - 04/2002
5Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 01/2007
5Feeding and Eating Disorders (Eating Disorder)
11/2020 - 03/2014
5Dyskinesias (Dyskinesia)
01/2020 - 06/2005
5Alzheimer Disease (Alzheimer's Disease)
01/2019 - 11/2011
5Spinal Cord Injuries (Spinal Cord Injury)
01/2018 - 09/2002
5Glioma (Gliomas)
03/2017 - 07/2005
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2016 - 01/2003
4Body Weight (Weight, Body)
07/2022 - 01/2012
4COVID-19
04/2022 - 01/2020
4Ulcerative Colitis
02/2022 - 06/2018
4Colitis
01/2022 - 08/2016
4Obesity
12/2021 - 01/2010
4Stroke (Strokes)
10/2021 - 03/2011
4Vomiting
01/2021 - 03/2014
4Wounds and Injuries (Trauma)
01/2020 - 04/2008
4Hypertension (High Blood Pressure)
12/2019 - 11/2013
4Thrombosis (Thrombus)
12/2019 - 04/2002
4Nephrotic Syndrome (Syndrome, Nephrotic)
01/2019 - 02/2011
4Frailty
12/2018 - 05/2015
4Carcinoma (Carcinomatosis)
10/2017 - 02/2007
4Insulin Resistance
01/2017 - 09/2007
3Non-alcoholic Fatty Liver Disease
07/2022 - 10/2012
3Osteolysis
02/2022 - 07/2015
3Cognitive Dysfunction
01/2022 - 11/2011
3Type 2 Diabetes Mellitus (MODY)
12/2021 - 01/2016
3Osteosarcoma (Osteogenic Sarcoma)
10/2021 - 01/2014
3Congenital Heart Defects (Congenital Heart Defect)
10/2021 - 09/2013
3Prostatic Neoplasms (Prostate Cancer)
05/2021 - 07/2014
3Headache (Headaches)
01/2021 - 07/2002

Drug/Important Bio-Agent (IBA)

39Proteins (Proteins, Gene)FDA Link
10/2022 - 03/2004
18Biomarkers (Surrogate Marker)IBA
06/2022 - 09/2013
10Pharmaceutical PreparationsIBA
05/2022 - 10/2003
10CytokinesIBA
01/2022 - 12/2012
9Interleukin-6 (Interleukin 6)IBA
08/2022 - 01/2017
9Biological ProductsIBA
11/2021 - 07/2005
8Anti-Bacterial Agents (Antibiotics)IBA
07/2022 - 01/2017
8RNA (Ribonucleic Acid)IBA
06/2022 - 02/2003
8Therapeutic UsesIBA
09/2021 - 08/2004
7EnzymesIBA
01/2022 - 01/2016
7MicroRNAs (MicroRNA)IBA
01/2018 - 09/2013
6Indicators and Reagents (Reagents)IBA
10/2022 - 02/2012
6LipidsIBA
10/2021 - 09/2007
6Messenger RNA (mRNA)IBA
09/2021 - 06/2012
6Complementary DNA (cDNA)IBA
11/2011 - 01/2000
5AntioxidantsIBA
12/2022 - 01/2016
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2022 - 12/2009
5human ERBB2 proteinIBA
05/2022 - 01/2020
5UbiquitinIBA
01/2022 - 12/2010
5Transcription Factors (Transcription Factor)IBA
12/2021 - 01/2010
5zeylenoneIBA
11/2021 - 08/2015
5p38 Mitogen-Activated Protein KinasesIBA
10/2019 - 07/2015
4CollagenIBA
12/2022 - 01/2013
4Interleukin-10 (Interleukin 10)IBA
08/2022 - 01/2013
4CalciumIBA
07/2022 - 01/2016
4Hormones (Hormone)IBA
02/2022 - 03/2014
4Hemoglobins (Hemoglobin)IBA
01/2022 - 08/2014
4AlbuminsIBA
01/2022 - 05/2015
4Immunotoxins (Immunotoxin)IBA
05/2021 - 01/2016
4AntibodiesIBA
11/2020 - 11/2004
4human PRRT2 proteinIBA
01/2020 - 12/2011
4NF-kappa B (NF-kB)IBA
10/2019 - 01/2008
4Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
10/2019 - 10/2017
4Glucose (Dextrose)FDA LinkGeneric
01/2017 - 09/2007
3VancomycinFDA LinkGeneric
08/2022 - 01/2017
3Parathyroid Hormone (Parathormone)IBA
07/2022 - 06/2016
3Dextrans (Dextran)FDA Link
02/2022 - 06/2018
3FlavonoidsIBA
02/2022 - 08/2016
3Phenobarbital (Luminal)FDA Link
02/2022 - 04/2019
3C-Reactive ProteinIBA
01/2022 - 12/2018
3cyclohexene oxideIBA
10/2021 - 10/2017

Therapy/Procedure

32Therapeutics
05/2022 - 01/2008
7Prostheses and Implants (Prosthesis)
02/2022 - 09/2009
7Hip Replacement Arthroplasty (Total Hip Replacement)
02/2022 - 06/2004
7Transplantation
01/2018 - 04/2008
6Aftercare (After-Treatment)
12/2022 - 05/2014
6Knee Replacement Arthroplasty (Total Knee Replacement)
03/2022 - 03/2011
5Bariatric Surgery
12/2021 - 08/2013
5Arthroplasty
06/2021 - 07/2020
5Drug Therapy (Chemotherapy)
01/2020 - 01/2014
4Length of Stay
12/2021 - 06/2011
4Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2020 - 02/2012